TGFB1 and diabetic kidney disease: In the context of diabetic nephropathy fibrosis, polyphenolic compounds significantly reduce the expression of fibrosis-related proteins by inhibiting the TGF-β/SMAD signaling pathway, thereby delaying or reversing the pathological progression of DN [107].